Tempus AI Inc.
Tempus AI Reports Q3 2024 Results and Ambry Genetics Acquisition
Summary
Tempus AI, Inc. reported a 33.0% year-over-year increase in revenue for the third quarter of 2024, reaching $180.9 million. The company also announced an agreement to acquire Ambry Genetics, a leader in genetic testing, for $375 million in cash and $225 million in shares. The acquisition is expected to enhance Tempus's hereditary cancer screening capabilities and expand its disease coverage. Additionally, Tempus provided financial guidance for the full year 2024, expecting revenue of approximately $700 million and an adjusted EBITDA of approximately ($105 million).
Profitelligence Alerts
Get alerts for TEM
Be first to know when Tempus AI Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Tempus AI Inc.
Tempus AI Inc. is a pioneering technology company specializing in the development and application of artificial intelligence solutions across various industries. Its primary function is to harness AI-driven insights to enhance operational efficiency and decision-making processes for enterprises. Tempus AI Inc. is at the forefront of integrating machine learning into sectors such as healthcare, finance, and logistics, where predictive data analytics can provide substantial competitive advantages. The company delivers bespoke AI platforms that enable organizations to streamline complex data sets into actionable intelligence. Its expertise extends to natural language processing and computer vision, offering comprehensive AI tools that drive innovation and efficiency. As a significant player in the tech market, Tempus AI Inc. contributes to setting industry standards for AI deployment, impacting how businesses leverage intelligent technology to improve outcomes and strategic planning. Founded with a mission to propel the development of intelligent systems, Tempus AI Inc. remains a vital contributor to the digital transformation of multiple industries, facilitating the transition towards a more data-driven future.
Official SEC Documents
Advertisement